UHS Investor presentation

Page 1

Universal Health Services, Inc. (UHS) is a holding company that operates through its subsidiaries. This document has been prepared by UHS of Delaware, Inc. Any reference to "UHS" or "UHS facilities" refers to UHS’ subsidiaries. Further, the terms "we," "us," "our" or "the company" refer to the operations of the subsidiaries of UHS. Any reference to employees refers to employment with a subsidiary of UHS. Investor Presentation Q2 2026 Update

Page 2

© 2026 UHS of Delaware, Inc. All Rights Reserved. 2 Disclaimer Numerous factors, including those disclosed herein, those related to healthcare industry trends and those detailed in our press release announcing our Second Quarter 2026 results dated July 27, 2026, filings with the Securities and Exchange Commission (as set forth in Item 1A-Risk Factors, and Item 7-Forward-Looking Statements and Risk Factors, in our Form 10-K for the year ended December 31, 2025 and in Item 1A-Risk Factors and Item 2. Management’s Discussion and Analysis of Financial Conditions and Results of Operations – Forward Looking Statements in our Form 10-Q for the quarter ended June 30, 2026), may cause the results to differ materially from those anticipated in the forward-looking statements. These statements are subject to risks and uncertainties and therefore actual results may differ materially. Readers are encouraged to read these materials in conjunction with this presentation material and should not place undue reliance on such forward-looking statements which reflect management's view only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. We believe that adjusted net income attributable to UHS, adjusted net income attributable to UHS per diluted share, EBITDA net of NCI and Adjusted EBITDA net of NCI, which are Non-GAAP financial measures ("GAAP" is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect of material items impacting our net income attributable to UHS, such as, changes in the value of certain non-marketable securities (in connection with our minority ownership in a healthcare generative artificial intelligence company), the impact of ASU 2016-09, and other potential material items that are nonrecurring or non-operational in nature including, but not limited to, impairments of goodwill, long-lived and intangible assets, reserves for various matters including settlements, legal judgments and lawsuits, costs related to extinguishment of debt, gains/losses on sales of assets and businesses, potential impacts of non-ordinary acquisitions, divestitures, joint ventures or other strategic transactions, and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. To obtain a complete understanding of our financial performance these measures should be examined in connection with net income attributable to UHS, as determined in accordance with GAAP , and as presented in the condensed consolidated financial statements and notes thereto in our filings with the Securities and Exchange Commission including our Report on Form 10-K for the year ended December 31, 2025 Item 1A-Risk Factors and Item 2. Management’s Discussion and Analysis of Financial Conditions and Results of Operations – Forward Looking Statements in our Form 10-Q for the quarter ended June 30, 2026. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP , these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance. See the Appendix to this Presentation for a Reconciliation of the Non-GAAP items to GAAP . Universal Health Services, Inc. (UHS) is a holding company that operates through its subsidiaries. This document has been prepared by UHS of Delaware, Inc. Any reference to "UHS" or "UHS facilities" refers to UHS’ subsidiaries. Further, the terms "we," "us," "our" or "the company" refer to the operations of the subsidiaries of UHS. Any reference to employees refers to employment with a subsidiary of UHS.

Page 3

© 2026 UHS of Delaware, Inc. All Rights Reserved. 3 Strategically Positioned to Deliver Long-Term Value Experienced & Innovative Leadership Team Long-tenured management team has successful long-term track record and strong shareholder alignment Presence in Attractive Markets Meaningfully scaled with 540+ inpatient and outpatient facility locations across 40 states, Washington, D.C., Puerto Rico and the U.K. Focused on geographic markets with strong demographics and population growth Multiple Growth Drivers Growth driven by organic (“same-facility”) performance, operating efficiency, disciplined internal and de novo expansion and selective acquisitions Quality Patient Care Culture that is committed to delivering high-quality patient care and service excellence Diversified Revenue Base Two operating segments – Acute Care Hospital Services and Behavioral Health Care Services – support diverse revenue base across service lines and payors Strong Financial Profile Consistent revenue, EBITDA, EPS and FCF growth accompanied by low leverage and robust capital returns to shareholders via buybacks and dividends

Page 4

© 2026 UHS of Delaware, Inc. All Rights Reserved. 4 Table of Contents About Us Our Portfolio Financial Highlights Founded in 1979, Universal Health Services, Inc. (NYSE: UHS) is one of the nation’s largest and most respected providers of hospital and healthcare services. UHS has built an impressive track record of achievement and performance, having grown steadily since our inception into an esteemed Fortune 500 corporation. We operate 540+ facilities across 40 states, the District of Columbia, Puerto Rico and the U.K. through two operating segments – Acute Care Hospital Services and Behavioral Health Care Services. We deliver exceptional, high-quality care supported by 101,500+ employees with assets that span the continuum of inpatient and outpatient services. During FY 2025, we generated Net revenue of $17.4 billion, Net income of $1.49 billion and Adjusted EBITDA- NCI of $2.59 billion. We consistently generate strong cash flow from operations which allows us to deploy capital towards routine and expansionary Capex, acquisitions, share buybacks and dividends.

Page 5

Page 6

© 2026 UHS of Delaware, Inc. All Rights Reserved. 6 To provide superior quality healthcare services that: Patients recommend to family and friends, Physicians prefer for their patients, Purchasers select for their clients, Employees are proud of, and Investors seek for long-term returns OUR MISSION Penned in 1979 by Alan B. Miller, Founder SINCE 1979

Page 7

© 2026 UHS of Delaware, Inc. All Rights Reserved. 7 Our Principles WE PROVIDE SUPERIOR QUALITY PATIENT CARE We strive to be the provider of choice because we are passionate about providing superior quality care for each patient we are privileged to serve. WE ARE COMMITTED TO BEING A HIGHLY ETHICAL HEALTHCARE PROVIDER We set higher ethical standards for ourselves because caring for our patients is a sacred trust. WE VALUE EACH MEMBER OF OUR TEAM AND ALL THEIR GOOD WORK We know that the quality of the patient experience is driven by the personal compassion, competence and commitment our team members deliver every day. WE ARE DEVOTED TO SERVING OUR LOCAL COMMUNITY Healthcare providers have always played a special role in the community, and we cherish that responsibility.

Page 8

© 2026 UHS of Delaware, Inc. All Rights Reserved. 8 Industry Accolades We are honored to receive industry accolades that recognize the care and services we provide. From Fortune, ©2025, 2026 Fortune Media IP Limited. All rights reserved. Used under license. 19 of 29 Acute Care Hospitals Scored A or B Leapfrog Safety Grade Spring 2026 16 consecutive years 22 years Ranked 271st 22 years Ranked 355th among U.S. companies 3 consecutive years

Page 9

© 2026 UHS of Delaware, Inc. All Rights Reserved. 9 UHS at a Glance 540+ hospitals and healthcare facilities across 40 states, Washington D.C., Puerto Rico and the United Kingdom with 2025 revenue of $17.4B. OUR PORTFOLIO AS OF JUNE 30, 2026 INPATIENT FACILITIES 376 LICENSED BEDS 32,086 OUTPATIENT LOCATIONS 168 ACUTE CARE BEHAVIORAL HEALTH INPATIENT FACILITIES 30 LICENSED BEDS 7,498 OUTPATIENT LOCATIONS 49 INPATIENT FACILITIES 346 LICENSED BEDS 24,588 OUTPATIENT LOCATIONS 119 OUR HEALTH CARE IMPACT (2025) PATIENT ENCOUNTERS 5.8M ADMISSIONS 820,807 PATIENT DAYS 8.1M ER VISITS 1.7M OUR PEOPLE (2025) EMPLOYEES 101,500 NURSES 25,800+ VETERANS HIRED IN 2025 1,495

Page 10

© 2026 UHS of Delaware, Inc. All Rights Reserved. 10 Strong Revenue Growth Profile Across Segments $12,642 $13,399 $14,282 $15,828 $17,365 2021 2022 2023 2024 2025 NET REVENUE ($ in millions) $7,108 $7,647 $8,081 $8,944 $9,926 $5,504 $5,730 $6,191 $6,873 $7,426 $30 $23 $10 $11 $13 2021 2022 2023 2024 2025 REVENUE BY SEGMENT ($ in millions) ACUTE CARE BEHAVIORAL HEALTH OTHER5-Yr. CAGR1: 8.5% ACUTE CARE – 5-Yr. CAGR1: 9.4% BEHAVIORAL HEALTH – 5 Yr. CAGR1: 7.3% Note: (1) 2020 -2025 CAGR.

Page 11

© 2026 UHS of Delaware, Inc. All Rights Reserved. 11 Highly Diversified Revenue and Payor Mix (2025) Medicare 15% Managed Medicare 17% Medicaid 13% Managed Medicaid 7% Managed Care 33% Other patient revenue and adjustments 6% Other non-patient revenue 9% ACUTE CARE HOSPITAL SERVICES 57% OF TOTAL REVENUE MIX BY SEGMENT & PAYOR Medicare 4% Managed Medicare 6% Medicaid 18% Managed Medicaid 24% Managed Care 22% U.K. 13% Other patient revenue and adjustments 9% Other non-patient revenue 3% BEHAVIORAL HEALTHCARE SERVICES 43% OF TOTAL Medicare 11% Managed Medicare 12% Medicaid 15% Managed Medicaid 14% Managed Care 28% U.K. 6% Other patient revenue and adjustments 7% Other non-patient revenue 6% REVENUE MIX BY PAYOR

Page 12

© 2026 UHS of Delaware, Inc. All Rights Reserved. 12 Strong Adjusted EBITDA & EPS Growth $1,900 $1,662 $1,742 $2,246 $2,590 $0 $500 $1,000 $1,500 $2,000 $2,500 $3,000 2021 2022 2023 2024 2025 ADJUSTED EBITDA NET OF NCI ($ in millions) $11.82 $9.88 $10.54 $16.61 $21.74 $0.00 $5.00 $10.00 $15.00 $20.00 $25.00 2021 2022 2023 2024 2025 ADJUSTED EPS ADJUSTED EPS 14.3% ADJUSTED EBITDA NET OF NCI 6.8% 5-YEAR CAGR1 Note: (1) 2020 -2025 CAGR.

Page 13

© 2026 UHS of Delaware, Inc. All Rights Reserved. 13 Long-term track record of disciplined capital deployment Cumulative Amounts 2021-2025 ($ in millions) INVESTMENT CAPITAL FOR GROWTH RETURNING CAPITAL TO SHAREHOLDERS Cash Flow from Operations $7,079 Capital Expenditures $4,292 Acquisition Capital $196 Dividends $284 Share Buyback1 $4,034 Note: (1) Reflects shares repurchased pursuant to buyback program.

Page 14

Page 15

Page 16

© 2026 UHS of Delaware, Inc. All Rights Reserved. 16 Acute Care Hospital Services ACUTE CARE HOSPITALS & OUTPATIENT FACILITIES PHYSICIAN PRACTICE MANAGEMENT MANAGED CARE KEY DEVELOPMENTS • Significant capacity brought on-line in existing markets (CA, FL, NV) during 2026 with 178 expansion beds adding 2.5% to total bed capacity • Three new Acute Care facilities added between late 2024 and 2026 including 156-bed de novo hospital in Palm Beach Gardens, Florida opened during Q2 2026 • Strong expense management due to productivity gains and supply chain efficiencies • Increased focus on outpatient development through FEDs, ASCs and other ambulatory sites • Active technology/AI deployments in administrative and clinical operations domains • High-performing health plan and ACO (Prominence) to drive value-based care in markets $9.9B Net Revenue 10-Yr. Avg. Same Facility Revenue Growth1 30 Hospitals 7,500 Beds 7 35 FEDs 14 Ambulatory Sites BY THE NUMBERS FinancialHighlights (2025) PortfolioStatistics Q2 2026 7.0% $1.4B Segment EBITDA States and Washington, D.C. Note: (1) 10-Year average 2016-2025.

Page 17

© 2026 UHS of Delaware, Inc. All Rights Reserved. Acute Care Market Overview 17 Size of the U.S. Acute Care Hospital market $1.7 TRILLION IN 2025 Strong market presence in core MSAs Many financially challenged Non-Profits Limited technology obsolescence risk for acute care services Stable pricing and long-term volume growth outlook Consistent cash flow generation Focus on markets growing more rapidly than the U.S. as a whole Recurring long-term demand due to increased healthcare needs within aging 65+ population

Page 18

© 2026 UHS of Delaware, Inc. All Rights Reserved. 18 Leadership in Acute Care Deliver superior quality care through 30 inpatient acute care hospitals, 35 freestanding emergency departments, 13 outpatient centers and 1 surgical hospital across 6 states and Washington D.C. California • Acute care portfolio concentrated in higher-growth markets with strong demographics • UHS acute care hospitals average ~250 licensed beds • 10-yr. average same-facility adjusted admissions growth of 2.5% and same-facility revenue per adjusted mission growth of 4.1% (2016 - 2025) • Experienced and disciplined local management teams with strong track records of success • Active technology agenda with successful deployments in clinical and administrative domains; increasingly leveraging AI capabilities within EHR platform Washington D.C. Nevada North Texas Florida Oklahoma South Carolina UHS ACUTE CARE STRENGTHS South Texas

Page 19

© 2026 UHS of Delaware, Inc. All Rights Reserved. 19 WASHINGTON, D.C. The George Washington University Hospital is a 395-bed academic medical center. In the U.S. News & World Report 2025-2026 Best Hospital Rankings, the hospital earned “High Performing” designations for six procedures & conditions and 1 specialty (Neurology & Neurosurgery). Cedar Hill Regional Medical Center opened in April 2025, granting access to quality care to all District residents, and in particular, residents of Ward 7 and 8. The full-service, 142-bed hospital offers trauma care, adult and pediatric emergency departments, maternal health and delivery, among other health and medical services. Our integrated network of care in D.C. also includes Cedar Hill Urgent Care, which was the first Urgent Care center in Ward 8 when it opened in 2022. FLORIDA The 295-bed Manatee Memorial Hospital, Manatee Diagnostic Centers and the Manatee Physician Alliance are in the Bradenton area. The hospital has two FEDs in Bradenton and one in Wimauma. The 120-bed Lakewood Ranch Medical Center earned its third consecutive Leapfrog Group's Hospital Safety Grade A in Fall 2025 as well as its 2025 Top Teaching Hospital Award. A ribbon-cutting ceremony for its new five-story patient tower was held in March 2026. Its FED, ER at Fruitville is in Sarasota County. The 235-bed Wellington Regional Medical Center (WRMC) and its FED, ER at Westlake, are in Palm Beach County. Palms Wellington Surgical Center is a joint venture between WRMC and physician owners. The seven-story 156-bed Alan B. Miller Medical Center in Palm Beach Gardens is named after UHS Founder and Executive Chairman. UHS’ 30th hospital opened during Q2 2026. Acute Care Markets

Page 20

© 2026 UHS of Delaware, Inc. All Rights Reserved. 20 Acute Care Markets SOUTH CAROLINA Aiken Regional Medical Centers offers a comprehensive range of services, including programs for cardiovascular conditions, orthopedics, women’s health, wound healing, neurosurgery and physical rehabilitation. It was awarded three 2025 Certified Zero Harm Awards from the South Carolina Hospital Association. Its Cancer Care Institute of Carolina, located on the hospital’s campus, offers advanced diagnostic imaging and a range of multidisciplinary services. ER at Sweetwater, an extension of Aiken Regional Medical Centers, is its FED that opened in August 2022. OKLAHOMA St. Mary’s Regional Medical Center, a 229-bed facility, has a long tradition of advanced and specialty care for stroke, joint replacement, women’s health, oncology and rehabilitation. This Enid-based facility was on Newsweek/Statista’s World’s Best Hospitals 2024-United States list (for the fourth- consecutive year) and the America's Best-in-State Hospitals list for Oklahoma in 2026. In 2025, St. Mary’s received the American Heart Association’s Get with the Guidelines®- Rural Stroke Gold Quality Achievement Award. It also was recently named to the 2026 Forbes Top Hospitals list.

Page 21

© 2026 UHS of Delaware, Inc. All Rights Reserved. 21 Acute Care Markets NORTHERN TEXAS Northwest Texas Healthcare System has nearly 500 beds, including a specialty Heart and Vascular Center, a children’s hospital as well as Northwest Texas Healthcare System Behavioral Health. It has four FEDs in Amarillo, including Northwest Emergency at Tascosa, which opened in February 2025, and Northwest Emergency on Eastern, which opened in June 2025. Surgery Center of Amarillo joined UHS through a joint venture with Regent and physicians in April 2024. The 414-bed Texoma Medical Center in Denison has a strong network of peripheral services including TMC Bonham Hospital, TMC Behavioral Health Center, five outpatient centers, two affiliated Urgent Care Centers and the FEDs ER at Anna, a Service of Texoma Medical Center, and ER at Sherman, a Service of Texoma Medical Center. SOUTH TEXAS The South Texas Health System in the Rio Grande Valley has four campuses (over 900 beds) with dedicated heart care and pediatric facilities. It also has seven FEDs, including its newest, South Texas Health System ER Pharr. For the fourth year in a row, the health system earned U.S. News & World Report’s Best Regional Hospital distinction for the McAllen Metro area. It also was awarded "High Performing" designations in 10 adult procedures/conditions. Doctors Hospital of Laredo,* which has more than 180 beds, opened its third FED, Doctors Hospital Emergency Room Wright Ranch, a Service of Doctors Hospital of Laredo, in February 2025. The 101-bed Fort Duncan Regional Medical Center provides hospital services in Eagle Pass and surrounding communities. In January 2025, the facility was recognized for being among the top 10% of 886 inpatient rehabilitation facilities and qualified to be ranked in Netsmart Technologies' IRF database. * Co-owned with physician investors.

Page 22

© 2026 UHS of Delaware, Inc. All Rights Reserved. 22 NEVADA The Valley Health System in Las Vegas has seven acute care hospitals, including a specialty hospital and West Henderson Hospital, which opened in December 2024. They, and the affiliated Desert View Hospital, total more than 2,040 beds. The system also includes nine FEDs, the Las Vegas Institute for Advanced Surgery* and two Behavioral Health facilities. The Northern Nevada Health System in greater Reno is comprised of two acute care facilities (282 total beds) located in Sparks and Reno, 70-bed Northwest Specialty Hospital, an affiliated Medical Group and Quail Surgical.** In January 2026, the health system opened its fourth FED, ER at North Valleys, in Reno. CALIFORNIA UHS offers a comprehensive network of care throughout Southern California: Southwest Healthcare. It is comprised of five inpatient acute care facilities that offer more than 820 beds, with Palmdale Regional Medical Center in Antelope Valley as well as Corona Regional Medical Center, Southwest Healthcare Rancho Springs Hospital, Southwest Healthcare Inland Valley Hospital and Temecula Valley Hospital in Riverside County. Southwest Healthcare Inland Valley Hospital held a ribbon-cutting ceremony for its new seven-story patient tower in February 2026. The expansion increases the hospital’s inpatient capacity by nearly 70%, to just over 200 beds. Its non-hospital access points include three A+ Urgent Care Centers,*** Apex Heart Specialists**** and Temecula Valley Day Surgery.***** UHS entered into a strategic alliance with Riverside Medical Clinic,*** a premier multi-specialty physician practice, in 2021. RMC has multiple locations in the Riverside area. *Jointly owned by an affiliate of The Valley Health System and community-based surgeons **Jointly owned by an affiliate of Northern Nevada Medical Center and community-based surgeons ***Physician-owned independent groups, managed by an affiliate ****Managed by an affiliate of Southwest Healthcare *****Majority owned by an affiliate Acute Care Markets

Page 23

© 2026 UHS of Delaware, Inc. All Rights Reserved. 8.6% -0.3% -0.6% 5.1% 5.4% 4.6% 2021 2022 2023 2024 2025 YTD Q2 2026 REVENUE PER ADJUSTED ADMISSION 23 Acute Care Key Operating Metrics (Same-Facility Basis) 6.4% 0.7% 6.4% 3.1% 1.3% 0.0% 7.7% 3.1% 7.6% 2.9% 1.6% 1.4% 2021 2022 2023 2024 2025 YTD Q2 2026 ADMISSIONS & ADJUSTED ADMISSIONS GROWTH Admissions Adjusted Admissions 11.6% 4.1% 7.6% 8.5% 8.5% 8.2% 2021 2022 2023 2024 2025 YTD Q2 2026 REVENUE GROWTH 66% 63% 65% 66% 65% 65% 2021 2022 2023 2024 2025 YTD Q2 2026 OCCUPANCY RATE

Page 24

© 2026 UHS of Delaware, Inc. All Rights Reserved. 2424 Behavioral Health Care Services BEHAVIORAL HEALTH INPATIENT & OUTPATIENT FACILITIES FREESTANDING OUTPATIENT CLINICS LEADING U.K. MENTAL HEALTH AND SOCIAL CARE SERVICES PROVIDER $7.4B Net Revenue 10-Yr. Avg. Same Facility Revenue Growth1 346 Hospitals 24,600 Beds 40 States, Puerto Rico and the U.K. 119 Outpatient Locations BY THE NUMBERS FinancialHighlights (2025) Portfolio Statistics Q2 2026 4.7% $1.7B Segment EBITDA KEY DEVELOPMENTS • Pending Talkspace acquisition on track to close during Q3 2026 and expected to accelerate growth in outpatient market • Disciplined capacity expansion in existing facilities with 470+ beds planned for 2026 including two de novo facilities • Increased focus on outpatient services for step-in and step-down levels of care, including active development pipeline of freestanding outpatient locations under Thousand Branches Wellness brand • U.K.-based Cygnet is a leading care provider with strong track record of growth and an attractive M&A pipeline LEADING VIRTUAL BEHAVIORAL HEALTHCARE COMPANY Acquisition with Talkspace, Inc. pending completion Note: (1) 10-Year average 2016-2025.

Page 25

© 2026 UHS of Delaware, Inc. All Rights Reserved. Behavioral Market Overview 25 Size of the Mental Health and Substance Use Disorder industry $95 BILLION IN 20251 61.5M people in the U.S. with diagnosable mental illness2 More than 1 in 5 U.S. adults live with a mental illness2 Increased demand for services in outpatient settings – both in-person and virtual Stable pricing and demand trends drive attractive growth and margins Minimal exposure to uncompensated care Lower capital requirements Source: 1) Precedence research; 2) Substance Abuse and Mental Health Services Administration (SAMHSA)

Page 26

© 2026 UHS of Delaware, Inc. All Rights Reserved. 26 Leadership in Behavioral Health UHS Behavioral Health Division reinforced its leadership position through continued commitment to patient safety and clinical excellence. Guided by a culture of empathy and collaboration, we continue to expand access and drive innovation across the continuum of care. BLACK BEAR LODGE CENTER FOR CHANGE CLIVE BEHAVIORAL HEALTH THE HUGHES CENTER HANOVER HILL BEHAVIORAL HEALTH MOUNTAIN YOUTH ACADEMY QUAIL RUN BEHAVIORAL HEALTH SEA GROVE RECOVERY SOUTHRIDGE BEHAVIORAL HOSPITAL VIA LINDA BEHAVIORAL HOSPITAL

Page 27

© 2026 UHS of Delaware, Inc. All Rights Reserved. 27 Behavioral Health Quality Indicators - 2025 • All UHS behavioral health facilities are fully accredited by The Joint Commission and/or Commission on Accreditation of Rehabilitation Facilities (CARF) • On key CMS quality metrics, our results continue to exceed the national average • Feedback from patient / parent surveys are indicators of the effectiveness of our treatment programming. 90% of PATIENTS SATISFIED WITH THEIR TREATMENT 89% of PATIENTS FELT BETTER AT DISCHARGE THAN WHEN ADMITTED Note: NPS uses a scale of -100 to 100. It measures the loyalty of consumers using the question: “How likely would you be to recommend this facility to a friend or family member?” Net Promoter, NPS and the NPS-related emoticons are registered U.S. trademarks, and Net Promoter Score and Net Promoter System are service marks of Bain & Company, Inc., Satmetix Systems, Inc. and Fred Reichheld. Source: Based on patient / informant satisfaction surveys. For more results, please read Our Impact in 2025 By the Numbers. AGREE THE ACADEMIC STAFF TRULY CARES ABOUT THEIR CHILD 89% of PATIENTS/GUARDIANS % of Respondents Who Indicated “Agree” or “Strongly Agree” Net Promoter Score of 45 is considered “Great” by industry standards.

Page 28

© 2026 UHS of Delaware, Inc. All Rights Reserved. 28 Behavioral Health Specialty Programming Evidence-based compassionate treatment services are available for children, adolescents, adults and seniors in inpatient, partial hospitalization and outpatient settings. Specialty treatment programs include: MILITARY – ACTIVE DUTY , VETERANS, FAMILIES SUBSTANCE USE DISORDERS EATING DISORDERS AUTISM SPECTRUM DISORDERS RESIDENTIAL TREATMENT

Page 29

© 2026 UHS of Delaware, Inc. All Rights Reserved. 29 Patriot Support Programs The UHS Patriot Support Programs provide a network of care across more than 30 UHS behavioral health facilities. These programs offer behavioral health services to active- duty military, veterans and their families. Programs and services are specifically designed to address the effects of combat stress, post-traumatic stress, depression, substance use and other behavioral health issues. Patriot Support Programs proudly offer: • Evidence-based programming with a focus on reintegration, resilience and post-traumatic growth • Close collaboration between facility staff and military base commanders • Streamlined admission process and expedient discharge planning • In-network TRICARE® and Veteran Affair Community Care Provider Note: TRICARE is a registered trademark of the Department of Defense, Defense Health Agency. All rights reserved. For more information visit patriotsupportprograms.com

Page 30

© 2026 UHS of Delaware, Inc. All Rights Reserved. 30 Behavioral Health Integrations In response to the significant rise in demand for behavioral health services, UHS works with leading health systems to develop: • Joint ventures • Partnerships • New care delivery models Integration of behavioral health and physical health services can decrease ED visits, reduce unnecessary inpatient admissions, enhance the patient experience and support compliance for better outcomes.

Page 31

© 2026 UHS of Delaware, Inc. All Rights Reserved. 31 Behavioral Health Key Operating Metrics (Same-Facility Basis) 5.4% 4.2% 8.0% 10.7% 7.7% 7.4% 2021 2022 2023 2024 2025 YTD Q2 2026 REVENUE GROWTH 6.7% 3.5% 5.9% 8.8% 6.8% 6.0% 2021 2022 2023 2024 2025 YTD Q2 2026 REVENUE PER ADJUSTED PATIENT DAY 71% 70% 72% 72% 73% 74% 2021 2022 2023 2024 2025 YTD Q2 2026 OCCUPANCY RATE 0.4% 1.2% 2.1% 1.7% 0.9% 1.5% 2021 2022 2023 2024 2025 YTD Q2 2026 ADJUSTED PATIENT DAY GROWTH

Page 32

© 2026 UHS of Delaware, Inc. All Rights Reserved. 32 On March 9, 2026, UHS announced it entered into a definitive agreement to acquire Talkspace, Inc. a leading virtual behavioral healthcare company that is trusted by patients, providers, payors and employers*. Key benefits include: • First National, Scaled End-to-End Continuum of Care to facilitate care access, seamless transitions across care settings and the ability to offer more flexible, stepped options for patients • Patient-Centric, Technology-Enabled Virtual Platform that is clinically driven, easy to use, fully encrypted and HIPAA-compliant • A Network of ~6,000 Licensed Professionals serving all 50 states, Washington, D.C., and Puerto Rico • Diversification of Payor Mix improving access for payors as well as consumers * Note: The transaction, which was approved by Talkspace's stockholders during Q2 2026, is expected to close during the third quarter of 2026 and is subject to satisfaction of regulatory approvals and other customary closing conditions Transaction Highlights ~$835M Total Enterprise Value $5.25 per share $229M 2025 Revenue

Page 33

Page 34

© 2026 UHS of Delaware, Inc. All Rights Reserved. 34 Second Quarter 2026 Highlights Consolidated FINANCIAL RESULTS $4,638.0 Net revenues $358.4 Net income attributable to UHS $677.9 Adjusted EBITDA net of NCI $5.98 Adjusted net income attributable to UHS per diluted share (“Adjusted EPS”) Acute Care Hospital Services SEGMENT FINANCIAL RESULTS $2,610.0 Net revenues 8.2% Same-facility revenue growth $334.6 Segment EBITDA 12.8% Segment EBITDA margin (-60 bps YoY) Behavioral Health Care Services SEGMENT FINANCIAL RESULTS $2,025.1 Net revenues 7.4% Same-facility revenue growth $470.0 Segment EBITDA 23.2% Segment EBITDA margin (-70 bps YoY) Note: Second quarter 2026 figures are for the three months ended June 30, 2026. See appendix for reconciliation of non -GAAP items Adjusted EPS, Adjusted EBITDA net of NCI, Segment Adjusted EBITDA Consolidated Net revenue growth of 8.3%, Adjusted EBITDA net of NCI growth of 5.4% and Adjusted EPS growth of 11.7% in Q2 2026 as compared to Q2 2025 Q2 2026 includes $25M net YoY benefit from out-of- period Medicaid supplemental payments including $100M in Q2 2026 and $75M in Q2 2025; Q2 2026 total net benefit from Medicaid supplemental funding sources was $442M as compared to $330M in Q2 2025 $ in millions except per share amounts

Page 35

© 2026 UHS of Delaware, Inc. All Rights Reserved. 35 Recent Performance $2,404 $2,610 $1,877 $2,025 $3 $3 Q2 2025 Q2 2026 REVENUE ($ in millions) NET REVENUES ACUTE CARE BEHAVIORAL HEALTH OTHER $4,638 $643 $678 Q2 2025 Q2 2026 ADJUSTED EBITDA1 ($ in millions) $5.35 $5.98 Q2 2025 Q2 2026 ADJUSTED EPS 1 $4,284 Note: Second quarter figures are for the three months ended June 30, 2025, and June 30, 2026. (1) See appendix for reconciliation of non -GAAP items Adjusted EPS, Adjusted EBITDA net of NCI, Segment Adjusted EBITDA

Page 36

© 2026 UHS of Delaware, Inc. All Rights Reserved. 36 Strong Cash Flow Profile $884 $996 $1,268 $2,067 $1,864 $845 2021 2022 2023 2024 2025 YTD Q2 2026 CASH FLOW FROM OPERATIONS ($ in millions) $856 $734 $743 $944 $1,015 $445 2021 2022 2023 2024 2025 YTD Q2 2026 CAPITAL EXPENDITURES ($ in millions) ($45) $198 $462 $1,063 $786 $363 2021 2022 2023 2024 2025 YTD Q2 2026 FREE CASH FLOW 1 ($ in millions) Note: (1) Free Cash Flow defined as Cash Flow From Operations less Capital Expenditures, Distributions to NCI, and Cash Dividends paid. See Appendix for reconciliation of non-GAAP measures

Page 37

© 2026 UHS of Delaware, Inc. All Rights Reserved. Capital Allocation Strategy Update 37 • Capital deployment prioritization centered on: • Expanding in existing markets through bed additions and development of outpatient access points • Selectively pursuing de novo and M&A opportunities that extend capabilities and geographic presence • Returning capital to shareholders via share buyback and dividends; $977M buyback authorization remaining as of June 30, 2026 • Continue to take a consistent and conservative approach to managing leverage and financial profile COMMENTARY $856 $734 $743 $944 $1,015 $955 $105 $20 $4 $19 $48 44 $1,201 $811 $524 $599 $899 $1,015 $66 $58 $55 $53 $51 $50 2021 2022 2023 2024 2025 LTM Q2 2026 CAPITAL ALLOCATION BY YEAR (IN $ MILLIONS) CapEx Acquisitions Share Repurchase Dividends Share repurchase reflects buybacks under publicly announced programs

Page 38

© 2026 UHS of Delaware, Inc. All Rights Reserved. 38 Disciplined Balance Sheet Management 2.1x 2.8x 2.8x 1.9x 1.8x 1.8 x 2021 2022 2023 2024 2025 Q2 2026 • Prudent balance sheet management, strong free cash flow and access to multiple capital markets • Trackrecord of maintaining conservativeleverageprofile with target range of 2x to 3x • Pro forma leverage for pending Talkspace, Inc. acquisition expected to be at low-end of target range NET LEVERAGE Net leverage calculated off total debt less cash and cash equivalents and based on LTM Adjusted EBITDA; See Appendix for reconciliation of non-GAAP measures

Page 39

© 2026 UHS of Delaware, Inc. All Rights Reserved. 39 EXPERIENCED LEADERSHIP QUALITY & SERVICES DIVERSE BUSINESS MIX FINANCIAL STRENGTH MULTIPLE GROWTH DRIVERS ATTRACTIVE MARKETS NET REVENUES 5-YEAR CAGR 8.5% 2025 $17.4B ADJUSTED EBITDA -NCI 5-YEAR CAGR 6.8% 2025 $2.6B ADJUSTED EPS 5-YEAR CAGR 14.3% 2025 $21.74 Our Strategy has Driven Consistent Long-term Growth Note: (1) 2020 -2025 CAGR.

Page 40

Page 41

© 2026 UHS of Delaware, Inc. All Rights Reserved. 41 2026 Operating Results Forecast UPDATED FORECAST AS OF JULY 27, 2026 Forecast Measure $ in millions except per share amounts Net revenues Adjusted EBITDA net of NCI Adjusted EPS Weighted average diluted share count (000s) Capital expenditures Interest expense Tax rate FY 2026 (Previous) Issued February 25, 2026 $18,417 to $18,789 $2,641 to $2,789 $22.64 to $24.52 60,349 $950 to $1,100 181 23.9% HIGHLIGHTS & KEY ASSUMPTIONS Acute Care Hospital Services same-facility revenue growth of 4.5% to 6.5%, driven by 1.5% to 2.5% volume and 3% to 4% pricing growth Pending Talkspace, Inc. acquisition expected to close mid-Q3 2026 and included in forecast 4.5% - 6.5% Behavioral Health Care Services same-facility revenue growth of 3% to 5%, driven by 1% to 2% volume and 2% to 3% pricing growth 3.0% - 5.0% Impact from Health Insurance Exchanges expected to be at upper half of guidance range or ~$85M Reiterate $35M impact from California staffing regulation Updated forecast assumes $1.5 Bln in Medicaid supplemental benefit or an increase of ~$150M, including $100M related to the 2025 Florida DPP program, growth in other programs and ~$25M from the Texas ATLIS program expected to be recorded in Q3 2026 Updated forecast assumes adverse pre-tax items as follows: ~$50M related to a San Antonio Behavioral Health facility subject to a CMS action, ~$50M due to slower ramping at an Acute Care facility opened during 2025, ~$50M related to higher professional and general liability expenses, and ~$50M related to lower volume assumptions for FY 2026 $18,501 to $18,762 $2,610 to $2,717 $22.28 to $23.65 59,369 $950 to $1,100 205 24.2% FY 2026 (Updated) Issued July 27, 2026 Other Items

Page 42

© 2026 UHS of Delaware, Inc. All Rights Reserved. 42 Calculation of Earnings/Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“EBITDA/Adjusted EBITDA Net of NCI”): Calculation of Free Cash Flow: Calculation of Net Leverage: $ in thousands FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 QTD Q2 2025 QTD Q2 2026 Net income attributable to UHS $991,590 $675,609 $717,795 $1,142,097 $1,488,796 $353,218 $358,447 Depreciation and amortization $533,213 $581,861 $568,041 $584,831 $618,743 $152,004 $167,338 Interest expense, net $83,672 $126,889 $206,674 $186,109 $156,068 $35,364 $39,912 Provision for income taxes $305,681 $209,278 $221,119 $334,827 $460,959 $110,773 $114,536 EBITDA net of NCI $1,914,156 $1,593,637 $1,713,629 $2,247,864 $2,724,566 $651,359 $680,233 Other (income) expense, net ($13,891) $10,406 $28,281 ($2,231) ($134,194) ($8,479) ($2,363) Provision for asset impairment $57,550 Adjusted EBITDA net of NCI $1,900,265 $1,661,593 $1,741,910 $2,245,633 $2,590,372 $642,880 $677,870 $ in thousands FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 YTD Q2 2026 Net Cash Provided by Operating Activities $883,695 $996,023 $1,267,797 $2,067,101 $1,864,397 $844,931 Less: Capital Expenditures ($855,659) ($734,001) ($743,055) ($943,810) ($1,015,152) ($444,790) Less: Distributions to Noncontrolling Interests ($7,080) ($5,391) ($6,830) ($6,508) ($11,734) ($24,760) Less: Regular Dividends ($65,896) ($58,449) ($55,480) ($53,346) ($51,267) ($11,889) Free Cash Flow ($44,940) $198,182 $462,432 $1,063,437 $786,244 $363,492 $ in thousands FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 QTD Q2 2026 Total Debt $4,190,288 $4,807,980 $4,912,469 $4,504,541 $4,752,551 $4,851,847 Total Cash $115,301 $102,818 $119,439 $125,983 $137,797 $138,800 Net Debt $4,074,987 $4,705,162 $4,793,030 $4,378,558 $4,614,754 $4,713,047 Adjusted EBITDA Net of NCI (last twelve months) $1,900,265 $1,661,593 $1,741,910 $2,245,633 $2,590,372 $2,675,430 Net Leverage (Net Debt / Adjusted EBITDA-NCI) 2.1x 2.8x 2.8x 1.9x 1.8x 1.8x

Page 43

© 2026 UHS of Delaware, Inc. All Rights Reserved. 43 Calculation of Adjusted Net Income Attributable to UHS Per Diluted Share ("Adjusted EPS") $ in thousands, except per share amounts FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 QTD Q2 2025 QTD Q2 2026 Net income attributable to UHS $991,590 $675,609 $717,795 $1,142,097 $1,488,796 $353,218 $358,447 Plus/minus after-tax adjustments: Unrealized loss (gain) on equity securities ($10,374) $10,580 $21,570 $1,985 ($12,061) ($4,534) Unrealized gain on non-marketable securities ($71,489) Impact of ASU 2016-09, net ($2,423) ($15,947) ($4,164) ($796) $0 Debt extinguishment costs $12,884 Provision for asset impairment $44,055 Adjusted net income attributable to UHS $991,677 $730,244 $739,365 $1,128,135 $1,401,082 $347,888 $358,447 Net income attributable to UHS per diluted share $11.82 $9.14 $10.23 $16.82 $23.10 $5.43 $5.98 Plus/minus after-tax adjustments per share: Unrealized loss on equity securities ($0.12) $0.14 $0.31 $0.03 ($0.19) ($0.07) Unrealized gain on non-marketable securities ($1.11) Impact of ASU 2016-09, net ($0.03) ($0.24) ($0.06) ($0.01) Debt extinguishment costs $0.15 Provision for asset impairment $0.60 Adjusted net income attributable to UHS per diluted share $11.82 $9.88 $10.54 $16.61 $21.74 $5.35 $5.98

Page 44

© 2026 UHS of Delaware, Inc. All Rights Reserved. 44 Three Months Ended March 31, 2025 Three Months Ended June 30, 2025 Three Months Ended Sept. 30, 2025 Three Months Ended Dec. 31, 2025 Twelve Months Ended Dec. 31, 2025 Three Months Ended March 31, 2026 Three Months Ended June 30, 2026 ($ in thousands) (unaudited) Net revenues $2,357,814 $2,403,837 $2,630,065 $2,545,579 $9,925,907 $2,610,136 $2,609,999 Income before income taxes $262,694 $228,313 $300,105 $258,298 $1,046,938 $287,761 $227,650 Depreciation and amortization 94,903 96,459 97,389 100,398 388,804 96,318 106,623 Interest expense, net 2,262 (1,613) 528 5,108 6,285 986 1,301 Other (income) expense, net (8,267) (916) (623) (11,727) (21,533) (2,132) (985) Segment EBITDA $351,592 $322,243 $397,399 $352,077 $1,420,494 $382,933 $334,589 Segment EBITDA margin 14.9% 13.4% 15.1% 13.8% 14.3% 14.7% 12.8% Calculation of Acute Care Hospitals Segment EBITDA

Page 45

© 2026 UHS of Delaware, Inc. All Rights Reserved. 45 Three Months Ended March 31, 2025 Three Months Ended June 30, 2025 Three Months Ended Sept. 30, 2025 Three Months Ended Dec. 31, 2025 Twelve Months Ended Dec. 31, 2025 Three Months Ended March 31, 2026 Three Months Ended June 30, 2026 ($ in thousands) (unaudited) Net revenues $1,739,064 $1,877,273 $1,860,259 $1,937,516 $7,425,500 $1,882,152 $2,025,065 Income before income taxes $335,522 $395,619 $345,266 $381,625 $1,460,503 $361,835 $410,837 Depreciation and amortization 51,152 53,170 55,294 60,503 220,464 56,634 58,895 Interest expense, net 1,075 1,104 1,265 666 4,110 1,272 1,273 Other (income) expense, net (825) (837) 733 (206) (1,135) (883) (983) Segment EBITDA $386,924 $449,056 $402,558 $442,588 $1,683,942 $418,858 $470,022 Segment EBITDA margin 22.2% 23.9% 21.6% 22.8% 22.7% 22.3% 23.2% Calculation of Behavioral Health Services Segment EBITDA

Slides